Both in Pharmaceuticals
Kiora Pharmaceuticals vs Enveric Biosciences
Over the past year KPRX returned −38.8% and ENVB returned −76.7%; their daily moves had a correlation of 0.05.
KPRX −38.8% ENVB −76.7%Growth of $1, one year, split-adjusted
| Metric | KPRX | ENVB |
|---|---|---|
| Price | $1.56 | $1.43 |
| Market cap | $6.9M | $6.4M |
| Today | −11.36% | −2.05% |
| 1 month | −39.5% | −2.1% |
| 6 months | −36.1% | −64.2% |
| Year to date | −20.8% | −60.6% |
| 1 year | −38.3% | −78.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $16.8M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 48.0% |
| Short % of float | 0.1% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).